• Abrahamsen, B., Hjelmborg, J., Kostenuik, P., Stilgren, L., Kyvik, K., Adamu, S., Brixen, K. & Langdahl, B. (2005) Circulating amounts of osteoprotegerin and RANK ligand: Genetic influence and relationship with BMD assessed in female twins. Bone 36, 727735.
  • Almasy, L. & Blangero, J. (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62, 11981211.
  • Brand, R. E., Nolen, B. M., Zeh, H. J., Allen, P. J., Eloubeidi, M. A., Goldberg, M., Elton, E., Arnoletti, J. P., Christein, J. D. & Vickers, S. M. (2011) Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res 17, 805816.
  • Brown, J., Vessella, R., Kostenuik, P., Dunstan, C., Lange, P. & Corey, E. (2001) Serum osteoprotegerin levels are increased in patients with advanced prostate cancer. Clin Cancer Res 7, 29772983.
  • Browner, W., Lui, L. & Cummings, S. (2001) Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86, 631637.
  • Cooper, C., Campion, G. & Melton, L. (1992) Hip fractures in the elderly: A world-wide projection. Osteoporos Int 2, 285289.
  • De Bruin, J., Bovenhuis, H., Van Noord, P., Pearson, P., Van Arendonk, J., Te Velde, E., Kuurman, W. & Dorland, M. (2001) The role of genetic factors in age at natural menopause. Hum Reprod 16, 20142018.
  • Ducy, P., Schinke, T. & Karsenty, G. (2000) The osteoblast: A sophisticated fibroblast under central surveillance. Science 289, 15011504.
  • Feigelson, H., Mckean-Cowdin, R., Pike, M., Coetzee, G., Kolonel, L., Nomura, A., Marchand, L. & Henderson, B. (1999) Cytochrome P450c17 alpha Gene (CYP17) polymorphism predicts use of hormone replacement therapy. Cancer Res 59, 39083910.
  • Gannage Yared, M. H., Fares, F., Semaan, M., Khalife, S. & Jambart, S. (2006) Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population. Clin Endocrinol 64, 652658.
  • Heath, A., Bucholz, K., Madden, P., Dinwiddie, S., Slutske, W., Bierut, L., Statham, D., Dunne, M., Whitfield, J. & Martin, N. (1997) Genetic and environmental contributions to alcohol dependence risk in a national twin sample: Consistency of findings in women and men. Psychol Med 27, 13811396.
  • Johnell, O. & Kanis, J. (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17, 17261733.
  • Jono, S., Ikari, Y., Shioi, A., Mori, K., Miki, T., Hara, K. & Nishizawa, Y. (2002) Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 106, 11921194.
  • Lacey, D., Timms, E., Tan, H., Kelley, M., Dunstan, C., Burgess, T., Elliott, R., Colombero, A., Elliott, G. & Scully, S. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165176.
  • Lau, E. (2002) Osteoporosis-a worldwide problem and the implications in Asia. Ann Acad Med Singapore 31, 6768.
  • Lindsay, R., Christiansen, C., Einhorn, T., Hart, D., Ljunghall, S., Mautalen, C., Meunier, P., Morii, H., Mundy, G. & Rapado, A. (1997) Who are candidates for prevention and treatment for osteoporosis. Osteoporos Int 7, 16.
  • Mei, J., Yeung, S. & Kung, A. (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86, 52175221.
  • Morinaga, T., Nakagawa, N., Yasuda, H., Tsuda, E. & Higashio, K. (1998) Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor. Eur J Biochem 254, 685691.
  • Murabito, J., Yang, Q., Fox, C., Wilson, P. & Cupples, L. (2005) Heritability of age at natural menopause in the Framingham Heart Study. J Clin Endocrinol Metab 90, 34273430.
  • Ng, M., Sham, P., Paterson, A., Chan, V. & Kung, A. (2006) Effect of environmental factors and gender on the heritability of bone mineral density and bone size. Ann Hum Genet 70, 428438.
  • Prescott, C., Aggen, S. & Kendler, K. (1999) Sex differences in the sources of genetic liability to alcohol abuse and dependence in a population-based sample of US twins. Alcohol Clin Exp Res 23, 11361144.
  • Simonet, W., Lacey, D., Dunstan, C., Kelley, M., Chang, M., Luthy, R., Nguyen, H., Wooden, S., Bennett, L. & Boone, T. (1997) Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89, 309319.
  • Teitelbaum, S. (2000) Bone resorption by osteoclasts. Science 289, 15041508.
  • Tsuda, E., Goto, M., Mochizuki, S., Yano, K., Kobayashi, F., Morinaga, T. & Higashio, K. (1997) Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Rese Commun 234, 137142.
  • Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., Nishihara, T., Koga, T., Martin, T. & Suda, T. (1990) Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A 87, 72607264.
  • Uemura, H., Yasui, T., Miyatani, Y., Yamada, M., Hiyoshi, M., Arisawa, K. & Irahara, M. (2008) Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women. Menopause 15, 180184.
  • Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K. & Kuriyama, M. (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139, 13291337.